These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20048394)

  • 1. Three years since the FDA advisory panel on drug-eluting stents: what have we learned about off-label use and stent thrombosis?
    Naidu SS
    J Invasive Cardiol; 2010 Jan; 22(1):20-1. PubMed ID: 20048394
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between off-label use of drug-eluting stents and subsequent stent thrombosis: a case-control analysis.
    Rabinovitz A; Bier DM; Wagman GM; Charlap E; Nazari R; Ghitelman J; Celaj S; Skeif B; Menegus M; Srinivas VS
    J Invasive Cardiol; 2010 Jan; 22(1):15-9. PubMed ID: 20048393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-label use of drug-eluting stents putting it in perspective.
    Grines CL
    J Am Coll Cardiol; 2008 Feb; 51(6):615-7. PubMed ID: 18261679
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on drug-eluting stents.
    Sims JM
    Dimens Crit Care Nurs; 2007; 26(6):237-40. PubMed ID: 18090139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A; Cosgrave J; Latib A; Colombo A
    Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stent thrombosis.
    Steinberg DH; Satler LF
    Minerva Cardioangiol; 2008 Feb; 56(1):127-37. PubMed ID: 18432175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent thrombosis following 2 drug-eluting stent implantations for coronary bifurcation lesion: a single-center analysis.
    Gao Z; Xu B; Yang Y; Chen J; Qiao S; Li JJ; Qin X; Wu Y; Yao M; Yuan J; Chen J; Liu H; Dai J; Gao RL
    J Interv Cardiol; 2010 Aug; 23(4):346-51. PubMed ID: 20718906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very late thrombosis of drug-eluting stents: a brief literature review and case example.
    Agarwal SK; Shawl F; Raman VK; Binbrek AS
    J Invasive Cardiol; 2008 Dec; 20(12):655-8. PubMed ID: 19057030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label use and the spectre of drug-eluting stent thrombosis.
    Cook S; Wenaweser P
    Circ Cardiovasc Interv; 2009 Aug; 2(4):273-6. PubMed ID: 20031728
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
    Ducrocq G; Serebruany V; Tanguay JF
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of unselected recipients of sirolimus-eluting stents: the Cypher stent U.S. post-marketing surveillance registry.
    Bezerra H; Perin E; Berger P; Block P; Ramee S; Katz S; Kellet M; Dippel E; Schaer G; Britto S; Cohen S; Costa M
    J Invasive Cardiol; 2010 Feb; 22(2):48-55. PubMed ID: 20124586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stents: issues of late stent thrombosis.
    Lemesle G; Maluenda G; Collins SD; Waksman R
    Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very late subacute thrombosis of a sirolimus-eluting stent after 57 months.
    Paturi A; Rothenberg M; Borzak S
    J Invasive Cardiol; 2009 Dec; 21(12):E252-3. PubMed ID: 19966378
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-eluting stent fracture and acute coronary syndrome.
    Chhatriwalla AK; Cam A; Unzek S; Bhatt DL; Raymond RE; Lincoff AM; Whitlow PL; Ellis SG; Tuzcu EM; Kapadia SR
    Cardiovasc Revasc Med; 2009; 10(3):166-71. PubMed ID: 19595398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry.
    Lagerqvist B; Carlsson J; Fröbert O; Lindbäck J; Scherstén F; Stenestrand U; James SK;
    Circ Cardiovasc Interv; 2009 Oct; 2(5):401-8. PubMed ID: 20031749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peeling-off labels mounting evidence for benefit of drug-eluting stents with off-label use.
    Büttner HJ; Neumann FJ
    J Am Coll Cardiol; 2007 Nov; 50(21):2037-8. PubMed ID: 18021869
    [No Abstract]   [Full Text] [Related]  

  • 19. Off-label use of stents: bare-metal versus drug-eluting stents.
    Girod JP; Mulukutla SR; Marroquin OC
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1095-106. PubMed ID: 18793112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late stent thrombosis thirteen months after drug-eluting stent implantation].
    Sacha J; Wester A; Pluta W
    Kardiol Pol; 2008 Jan; 66(1):78-80; discussion 84-5. PubMed ID: 18266191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.